Search Results - "SJOEGREN, Pia"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Macrophage Markers in Serum and Tumor Have Prognostic Impact in American Joint Committee on Cancer Stage I/II Melanoma by JENSEN, Trine O, SCHMIDT, Henrik, MØLLER, Holger Jon, HOYER, Morten, MANIECKI, Maciej Bogdan, SJOEGREN, Pia, CHRISTENSEN, Ib Jarle, STEINICHE, Torben

    Published in Journal of clinical oncology (10-07-2009)
    “…To evaluate the prognostic role of soluble CD163 (sCD163) in serum and macrophage infiltration in primary melanomas from patients with American Joint Committee…”
    Get full text
    Journal Article
  2. 2

    Serum YKL-40 Predicts Relapse-Free and Overall Survival in Patients With American Joint Committee on Cancer Stage I and II Melanoma by SCHMIDT, Henrik, JOHANSEN, Julia S, SJOEGREN, Pia, CHRISTENSEN, Ib J, SORENSEN, Boe S, FODE, Kirsten, LARSEN, Jorn, VON DER MAASE, Hans

    Published in Journal of clinical oncology (10-02-2006)
    “…To evaluate the novel tumor biomarker YKL-40 in serial serum samples from patients with American Joint Committee on Cancer (AJCC) stage I and II melanoma from…”
    Get full text
    Journal Article
  3. 3

    Mucosal Melanoma: a Literature Review by Yde, Simon Skovsted, Sjoegren, Pia, Heje, Martin, Stolle, Lars B.

    Published in Current oncology reports (01-03-2018)
    “…Purpose of review Mucosal melanoma is of great interest due to its aggressive behavior and less favorable prognosis. The literature is mainly case reports and…”
    Get full text
    Journal Article
  4. 4

    Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma by Jensen, Trine O., Schmidt, Henrik, Møller, Holger J., Donskov, Frede, Høyer, Morten, Sjoegren, Pia, Christensen, Ib J., Steiniche, Torben

    Published in Cancer (01-05-2012)
    “…BACKGROUND: Tumor cell and host immune cell interaction plays a key role in carcinogenesis. Signal transducer and activator of transcription 3 (STAT3) is…”
    Get full text
    Journal Article
  5. 5

    Extensive Pathological Analysis of Selected Melanoma Sentinel Lymph Nodes: High Metastasis Detection Rates at Reduced Workload by Riber-Hansen, Rikke, Sjoegren, Pia, Hamilton-Dutoit, Stephen Jacques, Steiniche, Torben

    Published in Annals of surgical oncology (01-05-2008)
    “…Background Extensive pathological workup of sentinel lymph nodes (SLNs) in melanoma detects more patients with metastasis-positive SLNs than do routine…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Automated digital volume measurement of melanoma metastases in sentinel nodes predicts disease recurrence and survival by Riber-Hansen, Rikke, Nyengaard, Jens R, Hamilton-Dutoit, Stephen J, Sjoegren, Pia, Steiniche, Torben

    Published in Histopathology (01-09-2011)
    “…Riber‐Hansen R, Nyengaard J R, Hamilton‐Dutoit S J, Sjoegren P & Steiniche T
(2011) Histopathology59, 433–440 Automated digital volume measurement of melanoma…”
    Get full text
    Journal Article
  9. 9

    Metastatic melanoma volume in sentinel nodes: objective stereology-based measurement predicts disease recurrence and survival by Riber-Hansen, Rikke, Nyengaard, Jens R, Hamilton-Dutoit, Stephen J, Sjoegren, Pia, Steiniche, Torben

    Published in Histopathology (01-06-2009)
    “…Aims:  Sentinel lymph node (SLN) status is the most important prognostic factor in intermediate thickness melanoma. The amount of metastatic disease in…”
    Get full text
    Journal Article
  10. 10

    Tumour-associated macrophages are related to progression in patients with metastatic melanoma following interleukin-2 based immunotherapy by Hansen, Bettina Dencker, Schmidt, Henrik, von der Maase, Hans, Sjoegren, Pia, Agger, Ralf, Hokland, Marianne

    Published in Acta oncologica (2006)
    “…The aim of the present study was to analyze whether leukocyte subsets in peripheral blood and tumour biopsies obtained before treatment were able to predict…”
    Get more information
    Journal Article
  11. 11

    Circulating Tyrosinase and MART-1 mRNA does not Independently Predict Relapse or Survival in Patients with AJCC Stage I–II Melanoma by Schmidt, Henrik, Sorensen, Boe S., Sjoegren, Pia, Christensen, Ib Jarle, Fode, Kirsten, Larsen, Jorn, Nexo, Ebba, von der Maase, Hans

    Published in Journal of investigative dermatology (01-04-2006)
    “…The detection of melanoma cells in peripheral blood has been proposed to select patients with a high risk of relapse. In this study, tyrosinase and melanoma…”
    Get full text
    Journal Article